ASPIRE BIOPHARMA HOLDINGS IN (ASBP) Stock Income Statement
NASDAQ:ASBP - US7389201077 - Common Stock
0.5566 USD
+0.02 (+4.47%)
0.565 USD
+0.01 (+1.51%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 16.42M | 3.09M | 1.34M | 980.00K | N/A | |||
| Selling, General, and Administrative Expenses | 15.80M | 3.09M | 1.34M | 980.00K | N/A | |||
| Operating Income | -16.42M | -3.09M | -1.34M | -980.00K | 0.00 | |||
| Interest Income/Expense | -1.95M | -342.90K | 5.80M | 4.32M | N/A | |||
| Other Income/Expense | N/A | -9.11M | N/A | N/A | N/A | |||
| Income Before Taxes | -27.39M | -12.54M | 4.46M | 3.34M | N/A | |||
| Net Income | -27.39M | -12.54M | 4.46M | 3.34M | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.68 | -1.52 | 0.23 | 0.11 | N/A | |||
| Statistics | ||||||||
All data in USD